The Hidden Cost of RUTF Stockouts in South Africa

The Hidden Cost of RUTF Stockouts in South Africa

When a clinic in rural South Africa opens its therapeutic feeding supplies and finds empty shelves, the consequences are biological, not administrative. A child with severe acute malnutrition who misses treatment faces a dramatically elevated risk of death. Yet across Africa, RUTF stockouts have shifted from isolated incidents to systemic crises.

In August 2025, Save the Children warned that the collapse in nutrition funding was predicted to cut off treatment for 15.6 million people across 18 countries  and that conditions were forecast to deteriorate further into 2026. As leading manufacturers of RUTF in India, Nuflower aims to support countries like South Africa in this fight against malnutrition.

    • The Crisis in Numbers
    • What Happens When Supply Fails
    • The Ripple Effect: Programs and Donors
    • What South African Organisations Must Do in 2026
    • FAQs

The Crisis in Numbers

Globally, 42.8 million children under five suffer from wasting at any given time. UNICEF, which procures roughly 80% of the world’s RUTF, delivered 5.2 million cartons across 66 countries in 2024, enough to treat 6.2 million children. That still falls far short of the 12.2 million who need immediate treatment.

RUTF funding peaked in 2022–2023, then dropped sharply due to major donor cuts. By mid-2025, Nigeria had secured only 64% of the 629,000 cartons needed for its lean season. Kenya’s stocks were projected to run out by October 2025. By early 2026, WFP warned that nearly 35 million Nigerians would face acute food insecurity during the 2026 lean season, the highest level in a decade.

When Supply Fails

UNICEF reports that nine out of ten children who receive a complete course of RUTF recover within weeks. When supply is interrupted, that pathway disappears. In South Sudan, only one-third of children requiring SAM treatment received it between January and July 2025, with 714,000 children at risk of severe acute malnutrition.

South Africa is not immune. Parliamentary data from December 2025 confirmed that between January and September 2025, at least 453 children under five died in public hospitals with MAM or SAM as an underlying condition, while over 9,479 were admitted for treatment. Separately, a 2025 study from KwaZulu-Natal’s Msinga sub-district found an acute malnutrition prevalence of 29% among under-five children, with CMAM strategies “inconsistently applied across facilities.

Looking for a reliable RUTF supplier with 60 MT/day capacity and 30,000+ MT track record?

Contact Nuflower Foods

The Ripple Effect: Programs and Donors

Stockouts dismantle the systems designed to save children. When CMAM programmes cannot guarantee supply, caregiver trust erodes and default rates climb.

Programmes that cannot demonstrate outcomes lose donor confidence, which shrinks budgets further. UNICEF confirms that RUTF funding is typically short-term, making procurement volumes volatile and forward planning nearly impossible. For South African organisations, supply chain reliability is not a logistics detail,  it is a programme performance metric that directly affects funding sustainability.

What South African Organisations Must Do in 2026

With 23% of South African children living in severe food poverty (UNICEF, June 2024) and IMAM guidelines mandating RUTF for SAM treatment, the supply question is urgent. Preventing RUTF supply chain failure requires a shift from reactive procurement to strategic resilience:

    • Pre-qualify multiple suppliers with capacity above 50 MT/day and certifications including FSSC 22000, GMP, and SEDEX. UNICEF’s own supplier base expanded to 23 manufacturers by 2025.
    • Establish rolling buffer stock agreements covering 3–6 months of supply, negotiated on annual volume commitments rather than spot purchases.
    • Evaluate the India–South Africa corridor. India is the world’s largest peanut producer. Direct manufacturers like Nuflower Foods offer competitive pricing without intermediary markups, with 60 MT/day capacity and supply across 20+ countries.

UNICEF estimates the total cost to treat a single child with severe wasting at approximately USD 100. This is not an impossible intervention. It is a vital one that remains financially fragile and supply diversification is the most direct protection available.

Frequently Asked Questions

What causes RUTF stockouts?

Stockouts are typically caused by unpredictable donor funding cycles, over-reliance on a narrow supplier base, rising raw material costs, and logistical disruptions. Funding disruptions or delays in sourcing can leave entire programmes without product for weeks.

How can organisations prevent RUTF supply disruptions?

The most effective strategies include diversifying across multiple pre-qualified suppliers, maintaining 3–6 months of buffer stock, investing in demand forecasting, and evaluating cost-efficient corridors such as the India–South Africa route. Partnering with direct manufacturers rather than intermediaries reduces both cost and lead-time risk.

Why should South African organisations consider Indian RUTF suppliers?

India is the world’s largest peanut producer, giving manufacturers a structural raw material advantage. The India–South Africa shipping corridor is direct and cost-efficient. Certified Indian manufacturers such as Nuflower Foods offer high production capacity, international certifications, and competitive pricing without intermediary markups.

RUTF stockouts are no longer isolated disruptions, they are systemic failures with life-or-death consequences for vulnerable children. As funding volatility, supplier concentration, and logistical challenges intensify, the ability to deliver consistent treatment is becoming one of the defining challenges in global nutrition.

For South African organisations, the path forward is clear: resilience must replace reactivity. Diversifying suppliers, securing buffer stock, and leveraging cost-efficient global corridors are not optional strategies, they are essential safeguards for programme continuity and donor confidence. With proven treatment outcomes and a relatively low cost per child, the real barrier is no longer feasibility, but reliability.

Ensuring uninterrupted access to RUTF is ultimately about protecting the most basic promise of healthcare: that when a child needs treatment, it is available.

 

Contact Nuflower Foods